S A Meyers-Pantele1, H J Rendina2, A J Talan2, O Shalhav2, S Lammert3, K J Horvath4. 1. Department of Psychology, San Diego State University, San Diego, CA, United States. Electronic address: sameyers@sdsu.edu. 2. PRIDE Health Research Consortium, Department of Psychology, Hunter College City University of New York, New York, NY, United States. 3. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, United States. 4. Department of Psychology, San Diego State University, San Diego, CA, United States.
Abstract
BACKGROUND: Racially diverse sexual minority men (SMM) are disproportionately impacted by the U.S. HIV epidemic. Substance use, particularly stimulant use, may impact viral suppression for SMM living with HIV. The current study sought to characterize patterns of substance use via latent class analysis (LCA) and test associations between those patterns and future viral load outcomes, among SMM living with HIV. METHODS: Data were drawn from Thrive With Me (TWM), an RCT of an mHealth intervention targeting ART adherence among SMM living with HIV. LCA was performed with six dichotomous indicators of substance use, derived from validated measures and urinalysis results, to determine substance use classes at baseline. Bivariate and multivariable logistic regression models tested associations between baseline substance use classes and HIV viral load 5-months post-baseline. RESULTS: Among 383 SMM living with HIV, we identified a three-class model of substance use fit best: low probability substance use (81.3 %), high probability hazardous alcohol, marijuana, and cocaine use (7.5 %), and high probability methamphetamine and amphetamine use (11.2 %). Additionally, the high probability amphetamine use class was less likely to be virally suppressed at 5-month follow-up compared to the low probability substance use class [Adjusted Odds Ratio = 3.34, 95 % Confidence Interval = 1.39-7.99, p = .0069]. CONCLUSION: We identified that some patterns of substance use (i.e., methamphetamine and amphetamine use), but possibly not others (e.g., alcohol, marijuana, and cocaine use), are potentially important intervention targets for improving HIV-related outcomes among racially diverse SMM living with HIV.
BACKGROUND: Racially diverse sexual minority men (SMM) are disproportionately impacted by the U.S. HIV epidemic. Substance use, particularly stimulant use, may impact viral suppression for SMM living with HIV. The current study sought to characterize patterns of substance use via latent class analysis (LCA) and test associations between those patterns and future viral load outcomes, among SMM living with HIV. METHODS: Data were drawn from Thrive With Me (TWM), an RCT of an mHealth intervention targeting ART adherence among SMM living with HIV. LCA was performed with six dichotomous indicators of substance use, derived from validated measures and urinalysis results, to determine substance use classes at baseline. Bivariate and multivariable logistic regression models tested associations between baseline substance use classes and HIV viral load 5-months post-baseline. RESULTS: Among 383 SMM living with HIV, we identified a three-class model of substance use fit best: low probability substance use (81.3 %), high probability hazardous alcohol, marijuana, and cocaine use (7.5 %), and high probability methamphetamine and amphetamine use (11.2 %). Additionally, the high probability amphetamine use class was less likely to be virally suppressed at 5-month follow-up compared to the low probability substance use class [Adjusted Odds Ratio = 3.34, 95 % Confidence Interval = 1.39-7.99, p = .0069]. CONCLUSION: We identified that some patterns of substance use (i.e., methamphetamine and amphetamine use), but possibly not others (e.g., alcohol, marijuana, and cocaine use), are potentially important intervention targets for improving HIV-related outcomes among racially diverse SMM living with HIV.
Authors: Kiffer G Card; Heather L Armstrong; Allison Carter; Zishan Cui; Lu Wang; Julia Zhu; Nathan J Lachowsky; David M Moore; Robert S Hogg; Eric A Roth Journal: Drug Alcohol Depend Date: 2018-05-22 Impact factor: 4.492
Authors: Adam W Carrico; Peter W Hunt; Torsten B Neilands; Samantha E Dilworth; Jeffrey N Martin; Steven G Deeks; Elise D Riley Journal: J Acquir Immune Defic Syndr Date: 2019-01-01 Impact factor: 3.731
Authors: Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak Journal: AIDS Date: 2004-01-01 Impact factor: 4.177
Authors: Kiffer G Card; Heather L Armstrong; Allison Carter; Zishan Cui; Lu Wang; Julia Zhu; Nathan J Lachowsky; David M Moore; Robert S Hogg; Eric A Roth Journal: Cult Health Sex Date: 2018-03-28
Authors: Rachel E Gicquelais; Becky L Genberg; Jacquie Astemborski; David D Celentano; Gregory D Kirk; Shruti H Mehta Journal: AIDS Educ Prev Date: 2019-08
Authors: Adam W Carrico; Jennifer Jain; Michael V Discepola; David Olem; Rick Andrews; William J Woods; Torsten B Neilands; Steven Shoptaw; Walter Gómez; Samantha E Dilworth; Judith T Moskowitz Journal: BMC Public Health Date: 2016-07-30 Impact factor: 3.295